Lantern Pharma Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Lantern Pharma Inc. (LTRN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 10.90 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-10
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 11.17M shares, a 79.10% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 11.19M shares, a 79.91% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 11.18M shares, a 311.21% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 10.07M shares, a 398.51% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 10.90M shares, a 153.31% increase from fiscal 2020.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 4.30M shares, a 117.61% increase from fiscal 2019.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 1.98M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 11.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 11.18M shares derived: average of 2 quarters · filed 2022-03-10 | 11.18M shares derived: average of 3 quarters · filed 2022-03-10 | 10.90M shares 10-K · filed 2022-03-10 |
| 2021-09-30 | 11.19M shares 10-Q · filed 2021-11-01 | 11.18M shares derived: average of 2 quarters · filed 2021-11-01 | 10.82M shares 10-Q · filed 2021-11-01 | 9.67M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2021-06-30 | 11.18M shares 10-Q · filed 2021-07-29 | 10.63M shares 10-Q · filed 2021-07-29 | 9.16M shares derived: average of 3 quarters · filed 2022-03-10 | 8.43M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2021-03-31 | 10.07M shares 10-Q · filed 2021-05-03 | 8.15M shares derived: average of 2 quarters · filed 2022-03-10 | 7.51M shares derived: average of 3 quarters · filed 2022-03-10 | 6.31M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | 6.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 6.23M shares derived: average of 2 quarters · filed 2022-03-10 | 5.06M shares derived: average of 3 quarters · filed 2022-03-10 | 4.30M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 6.22M shares 10-Q · filed 2021-11-01 | 4.47M shares derived: average of 2 quarters · filed 2021-11-01 | 3.66M shares 10-Q · filed 2021-11-01 | 3.23M shares derived: average of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | 2.72M shares 10-Q · filed 2021-07-29 | 2.37M shares 10-Q · filed 2021-07-29 | 2.24M shares derived: average of 3 quarters · filed 2021-07-29 | 2.17M shares derived: average of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | 2.02M shares 10-Q · filed 2021-05-03 | 2.00M shares derived: average of 2 quarters · filed 2021-05-03 | 1.99M shares derived: average of 3 quarters · filed 2021-05-03 | 1.99M shares derived: average of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | 1.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 1.98M shares derived: average of 2 quarters · filed 2021-03-10 | 1.98M shares derived: average of 3 quarters · filed 2021-03-10 | 1.98M shares 10-K · filed 2021-03-10 |
| 2019-09-30 | 1.98M shares 10-Q · filed 2020-10-29 | 1.98M shares derived: average of 2 quarters · filed 2020-10-29 | 1.98M shares 10-Q · filed 2020-10-29 | |
| 2019-06-30 | 1.98M shares 10-Q · filed 2020-07-30 | 1.98M shares 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |